Filter News
Area of Research
- Advanced Manufacturing (8)
- Biology and Environment (15)
- Clean Energy (60)
- Computational Engineering (1)
- Computer Science (5)
- Electricity and Smart Grid (1)
- Fuel Cycle Science and Technology (1)
- Functional Materials for Energy (2)
- Fusion and Fission (13)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (3)
- Materials (48)
- Materials for Computing (5)
- National Security (13)
- Neutron Science (18)
- Nuclear Science and Technology (10)
- Quantum information Science (2)
- Sensors and Controls (1)
- Supercomputing (47)
News Type
News Topics
- (-) 3-D Printing/Advanced Manufacturing (50)
- (-) Artificial Intelligence (32)
- (-) Biomedical (18)
- (-) Composites (10)
- (-) Energy Storage (45)
- (-) Frontier (17)
- (-) Machine Learning (14)
- (-) Nuclear Energy (33)
- (-) Quantum Science (28)
- (-) Security (11)
- Advanced Reactors (12)
- Big Data (11)
- Bioenergy (24)
- Biology (22)
- Biotechnology (7)
- Buildings (15)
- Chemical Sciences (33)
- Clean Water (2)
- Climate Change (25)
- Computer Science (62)
- Coronavirus (17)
- Critical Materials (11)
- Cybersecurity (18)
- Decarbonization (22)
- Education (3)
- Element Discovery (1)
- Environment (44)
- Exascale Computing (12)
- Fossil Energy (1)
- Fusion (14)
- Grid (18)
- High-Performance Computing (33)
- Irradiation (1)
- Isotopes (21)
- ITER (2)
- Materials (67)
- Materials Science (53)
- Mercury (2)
- Microelectronics (1)
- Microscopy (18)
- Molten Salt (2)
- Nanotechnology (28)
- National Security (20)
- Net Zero (4)
- Neutron Science (56)
- Partnerships (28)
- Physics (24)
- Polymers (13)
- Quantum Computing (10)
- Renewable Energy (1)
- Simulation (11)
- Software (1)
- Space Exploration (3)
- Statistics (1)
- Summit (22)
- Sustainable Energy (37)
- Transformational Challenge Reactor (4)
- Transportation (32)
Media Contacts
ORNL and The University of Toledo have entered into a memorandum of understanding for collaborative research.
Processes like manufacturing aircraft parts, analyzing data from doctors’ notes and identifying national security threats may seem unrelated, but at the U.S. Department of Energy’s Oak Ridge National Laboratory, artificial intelligence is improving all of these tasks.
Three researchers at Oak Ridge National Laboratory will lead or participate in collaborative research projects aimed at harnessing the power of quantum mechanics to advance a range of technologies including computing, fiber optics and network
Craig Blue, a program director at the Department of Energy’s Oak Ridge National Laboratory, has been elected a 2019 fellow for SME (formerly known as the Society for Manufacturing Engineers).
IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.
A team led by scientists at the Department of Energy’s Oak Ridge National Laboratory explored how atomically thin two-dimensional (2D) crystals can grow over 3D objects and how the curvature of those objects can stretch and strain the
OAK RIDGE, Tenn., May 8, 2019—Oak Ridge National Laboratory and Lincoln Electric (NASDAQ: LECO) announced their continued collaboration on large-scale, robotic additive manufacturing technology at the Department of Energy’s Advanced Manufacturing InnovationXLab Summit.
OAK RIDGE, Tenn., May 7, 2019—The U.S. Department of Energy today announced a contract with Cray Inc. to build the Frontier supercomputer at Oak Ridge National Laboratory, which is anticipated to debut in 2021 as the world’s most powerful computer with a performance of greater than 1.5 exaflops.
OAK RIDGE, Tenn., May 7, 2019—Energy Secretary Rick Perry, Congressman Chuck Fleischmann and lab officials today broke ground on a multipurpose research facility that will provide state-of-the-art laboratory space
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.